TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 277246

Group type: EXPERIMENTAL
Intervention: Misonidazole for the radiotherapy of Grades 3 and 4 cerebral astrocytoma
Number of subjects: 10
Study: 31209192

Group type: EXPERIMENTAL
Intervention: Trimetazidine (70mg/d) for 72 hours
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no trimetazidine)
Number of subjects: 100
Study: 27606545

Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg once weekly for 24 weeks
Number of subjects: 373
Study: 25740675

Group type: EXPERIMENTAL
Intervention: Group CBT session (120 min) + web-based CBT homework for 1 month
Number of subjects: 84
Study: 23786282

Group type: EXPERIMENTAL
Intervention: SIT (Specific Immunotherapy)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 21088593

Group type: EXPERIMENTAL
Intervention: Macintosh
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Glidescope Video Laryngoscope
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Truview EVO2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Airtraq
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intermediate to difficult comparison
Number of subjects: 20

Group type: COMPARATOR
Intervention: Laryngoscopic view and time to intubate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ease of laryngoscopy (VAS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ease of intubation (VAS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tongue compression score
Number of subjects: 20

Group type: COMPARATOR
Intervention: Number of attempts
Number of subjects: 20
Study: 19144501

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 17219226

Group type: EXPERIMENTAL
Intervention: Early start of OKC quadriceps exercises (P4)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Late start of OKC quadriceps exercises (P12)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Early start of OKC quadriceps exercises (H4)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Late start of OKC quadriceps exercises (H12)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Quadriceps muscle torques
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Hamstring muscle torques
Number of subjects: 68
Study: 15531661

Group type: EXPERIMENTAL
Intervention: Plant sterols
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Combination of plant sterols and exercise
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 84
Study: 11319935

Group type: EXPERIMENTAL
Intervention: Nonfatigued state
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Fatigued state
Number of subjects: 37
Study: 9272403

Group type: EXPERIMENTAL
Intervention: Moxonidine 0.4 mg once daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Moxonidine 0.4 mg once daily with lorazepam
Number of subjects: 48
Study: 7892973

Group type: EXPERIMENTAL
Intervention: P6 acupressure
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 46
Study: 6373039

Group type: EXPERIMENTAL
Intervention: 5 micrograms/kg of ivermectin
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 10 micrograms/kg of ivermectin
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 30 micrograms/kg of ivermectin
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 50 micrograms/kg of ivermectin
Number of subjects: 32
Study: 30597551

Group type: EXPERIMENTAL
Intervention: Guided internet CBT (iCBT)
Number of subjects: 89
Study: 29987442

Group type: EXPERIMENTAL
Intervention: TTM-based educational intervention conducted over five sessions
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: TTM-based educational intervention
Number of subjects: 102
Study: 23665885

Group type: EXPERIMENTAL
Intervention: Taurolidine-citrate-heparin lock solution
Number of subjects: 29

Group type: COMPARATOR
Intervention: Heparin filling
Number of subjects: 29
Study: 24502842

Group type: EXPERIMENTAL
Intervention: Tonic heat pain (46 °C) on the right leg for 7 minutes
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Cold pressor pain (1 °C to 4 °C) on the left hand for 5 minutes
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Pressure pain thresholds (PPT) measured at heterotopic and homotopic locations
Number of subjects: 41
Study: 22172428

Group type: EXPERIMENTAL
Intervention: Gold kiwifruit (4 kiwifruit daily)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Banana (2 bananas daily)
Number of subjects: 32
Study: 20420510

Group type: EXPERIMENTAL
Intervention: Pegylated interferon alfa-2a (180 microg weekly for 12 weeks)
Number of subjects: 11
Study: 17394626

Group type: EXPERIMENTAL
Intervention: Ibuprofen-foam dressing
Number of subjects: 24

Group type: COMPARATOR
Intervention: Local best practice
Number of subjects: 24
Study: 17129441

Group type: EXPERIMENTAL
Intervention: Intradermic suture
Number of subjects: 200

Group type: COMPARATOR
Intervention: Para-position suture
Number of subjects: 200
Study: 15575122

Group type: EXPERIMENTAL
Intervention: Fall prevention program including exercise
Number of subjects: 187

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 187
Study: 10988044

Group type: EXPERIMENTAL
Intervention: Paracetamol 1 g taken 30 min before HSG
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 8841797

Group type: EXPERIMENTAL
Intervention: S-adenosylmethionine (SAMe) 1000 mg/day i.m.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ursodeoxycholic acid (UDCA) 450 mg/day
Number of subjects: 20
Study: 1739153

Group type: EXPERIMENTAL
Intervention: Mailing information to businesses about the no-smoking law
Number of subjects: 299

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 299
Study: 6715724

Group type: EXPERIMENTAL
Intervention: Flurbiprofen, 75 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine, 6 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Flurbiprofen + Chlorpheniramine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 31791370

Group type: EXPERIMENTAL
Intervention: Healthy lifestyle modification based on traditional Chinese medicine (TCM)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (routine patient education)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Healthy lifestyle modification based on TCM
Number of subjects: 56
Study: 28417992

Group type: EXPERIMENTAL
Intervention: Eluxadoline 75 mg
Number of subjects: 2428

Group type: EXPERIMENTAL
Intervention: Eluxadoline 100 mg
Number of subjects: 2428

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2428
Study: 25416193

Group type: EXPERIMENTAL
Intervention: High-intensity interval exercise
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Moderate-intensity endurance exercise
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 17
Study: 24079823

Group type: EXPERIMENTAL
Intervention: Electroacupuncture with deep needling at acupuncture points BL33 and BL35
Number of subjects: 500

Group type: COMPARATOR
Intervention: Sham electroacupuncture with non-penetrating needling at sham locations for acupuncture points BL33 and BL35
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 500
Study: 22197955

Group type: EXPERIMENTAL
Intervention: High-energy and high-fat meal
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Moderate-energy and high-carbohydrate meal
Number of subjects: 3

Group type: COMPARATOR
Intervention: Fasting (no meal)
Number of subjects: 3
Study: 19150590

Group type: EXPERIMENTAL
Intervention: Confrontational counselling with spirometry
Number of subjects: 228

Group type: COMPARATOR
Intervention: Conventional health education and promotion (control group)
Number of subjects: 228
Study: 16718629

Group type: EXPERIMENTAL
Intervention: Valsartan (n = 8)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Atenolol (n = 10)
Number of subjects: 18
Study: 15337695

Group type: EXPERIMENTAL
Intervention: Nesiritide (2 microg/kg IV bolus followed by an infusion of 0.01 microg/kg per minute)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 11547716

Group type: EXPERIMENTAL
Intervention: Lorazepam (2 mg)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Diazepam (5 mg)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 205
Study: 9257066

Group type: EXPERIMENTAL
Intervention: Different radiation doses
Number of subjects: 0
Study: 8329252

Group type: EXPERIMENTAL
Intervention: Nasal administration of midazolam 0.2 mg kg‐1
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Rectal administration of midazolam 0.2 mg kg‐1
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Intravenous administration of midazolam 0.2 mg kg‐1
Number of subjects: 45
Study: 3518624

Group type: EXPERIMENTAL
Intervention: Bismuth subsalicylate (2.1 g/day on a twice‐daily regimen)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Bismuth subsalicylate (1.05 g/day on a twice‐daily regimen)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Bismuth subsalicylate (active medication)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 231
Study: 28868637

Group type: EXPERIMENTAL
Intervention: Self-assembling peptide P11-4
Number of subjects: 26
Study: 27655538

Group type: EXPERIMENTAL
Intervention: Zinc supplement (zinc gluconate granules for 10 days)
Number of subjects: 103
Study: 25587218

Group type: EXPERIMENTAL
Intervention: Support group led by a social worker (10 sessions)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 36
Study: 21163600

Group type: EXPERIMENTAL
Intervention: 100 kV TRO-CTA protocol (group 2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 120 kV standard protocol (group 1)
Number of subjects: 60
Study: 20604703

Group type: EXPERIMENTAL
Intervention: Extended cognitive behavior therapy for cigarette smoking cessation
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Model 1 (pretreatment factors, demographic characteristics, treatment assignment)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Model 2 (Model 1 variables + clinical data during treatment)
Number of subjects: 301
Study: 18563952

Group type: EXPERIMENTAL
Intervention: Natalizumab
Number of subjects: 0
Study: 15954812

Group type: EXPERIMENTAL
Intervention: Er:YAG laser 60 mJ/2 Hz (G2)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Er:YAG laser 80 mJ/2 Hz (G3)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Er:YAG laser 100 mJ/2 Hz (G4)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (G1)
Number of subjects: 48
Study: 12038906

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 9691858

Group type: EXPERIMENTAL
Intervention: midazolam 0.03 mg kg‐1 i.v.
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: midazolam 0.06 mg kg‐1 i.v.
Number of subjects: 28
Study: 7661381

Group type: EXPERIMENTAL
Intervention: CO2-rich spa gas
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water-vapor-saturated air
Number of subjects: 10
Study: 2475322

Group type: EXPERIMENTAL
Intervention: Ethanol (0.75 mg/kg)
Number of subjects: 24
Study: 791434

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHD) for irrigation of vas
Number of subjects: 61

Group type: COMPARATOR
Intervention: Sterile water for irrigation of vas
Number of subjects: 61

Group type: COMPARATOR
Intervention: Non-irrigated group
Number of subjects: 61

Group type: COMPARATOR
Intervention: Water for irrigation of vas
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Trypan blue uptake test
Number of subjects: 61
Study: 28100629

Group type: EXPERIMENTAL
Intervention: Chronocort (modified-release hydrocortisone)
Number of subjects: 18
Study: 25385878

Group type: EXPERIMENTAL
Intervention: Nicotine inhaler device (0.22 mg, 0.45 mg, 0.67 mg doses)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nicotine inhaler device (0.67 mg repeated hourly for 12 hr)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nicotine inhaler device
Number of subjects: 36
Study: 23490435

Group type: EXPERIMENTAL
Intervention: Glucose and protein ingestion at rest (RGP)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Glucose ingestion at rest (RG)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Glucose and protein ingestion after exercise (EGP)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Glucose ingestion after exercise (EG)
Number of subjects: 21
Study: 21670283

Group type: EXPERIMENTAL
Intervention: Prompt to write down just a date
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prompt to write down both a date and a time
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no prompt)
Number of subjects: 0
Study: 19487269

Group type: EXPERIMENTAL
Intervention: golimumab 50 or 100 mg every 2 or 4 weeks + MTX
Number of subjects: 171

Group type: COMPARATOR
Intervention: MTX alone (placebo + MTX)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: golimumab + MTX
Number of subjects: 171
Study: 16688035

Group type: EXPERIMENTAL
Intervention: CHARITE Artificial Disc (TDR)
Number of subjects: 688

Group type: COMPARATOR
Intervention: ALIF with threaded fusion cages and autograft (Control)
Number of subjects: 688
Study: 14769595

Group type: EXPERIMENTAL
Intervention: 0.2% brimonidine tartrate
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 2% dorzolamide hydrochloride
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination of brimonidine and dorzolamide
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11732521

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Droperidol 1.25 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 120
Study: 8922654

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy
Number of subjects: 22
Study: 1425726

Group type: EXPERIMENTAL
Intervention: Imipenem/cilastatin
Number of subjects: 337

Group type: COMPARATOR
Intervention: Cefotaxime/gentamicin (plus metronidazole for suspected anaerobe infection)
Number of subjects: 337

Group type: COMPARATOR
Intervention: Cefotaxime/gentamicin
Number of subjects: 337
Study: 3907843

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 12.5 mg OD
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 25 mg OD
Number of subjects: 12

Group type: COMPARATOR
Intervention: Captopril 50 mg BID
Number of subjects: 12
Study: 30001703

Group type: EXPERIMENTAL
Intervention: Positive STEPS intervention (two-way daily text messaging as a reminder system, progressing to in-person counseling if needed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 0
Study: 28956786

Group type: EXPERIMENTAL
Intervention: Liraglutide added to insulin for 26 weeks
Number of subjects: 71

Group type: COMPARATOR
Intervention: Standard insulin therapy
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Liraglutide added to insulin for 8 weeks
Number of subjects: 71
Study: 24165860

Group type: EXPERIMENTAL
Intervention: Physical activity adoption via motivational interviewing
Number of subjects: 184

Group type: COMPARATOR
Intervention: Physical activity adoption via education
Number of subjects: 184
Study: 24490058

Group type: EXPERIMENTAL
Intervention: Glucomannan (1.33 grams taken with 236.6 mL of water before meals)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo (identically looking capsules taken with 236.6 mL of water before meals)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Glucomannan
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Glucomannan and Placebo
Number of subjects: 53
Study: 21996369

Group type: EXPERIMENTAL
Intervention: Intrathecal methotrexate, n = 197
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: High-dose intravenous methotrexate (HDM), n = 79
Number of subjects: 555

Group type: COMPARATOR
Intervention: All patient groups (n = 555)
Number of subjects: 555
Study: 18281791

Group type: EXPERIMENTAL
Intervention: High-frequency radiosurgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional diathermy
Number of subjects: 60
Study: 16990385

Group type: EXPERIMENTAL
Intervention: BMC
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: CPC
Number of subjects: 75

Group type: COMPARATOR
Intervention: No infusion
Number of subjects: 75
Study: 14680337

Group type: EXPERIMENTAL
Intervention: Continuous-combined estrogen plus progestin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estrogen alone (ongoing trial)
Number of subjects: 0
Study: 11059442

Group type: COMPARATOR
Intervention: Antidepressant therapy (including tricyclic antidepressants such as amitriptyline, clomipramine, desipramine, doxepin, trimipramine, and the antiserotonin agent mianserin)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 8809640

Group type: EXPERIMENTAL
Intervention: Prophylactic G-CSF
Number of subjects: 606

Group type: COMPARATOR
Intervention: Control (no G-CSF)
Number of subjects: 606
Study: 1736695

Group type: EXPERIMENTAL
Intervention: Intravenous diclofenac 75 mg loading dose followed by 5 mg/hour infusion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intravenous diclofenac
Number of subjects: 40
Study: 6744777

Group type: EXPERIMENTAL
Intervention: Diltiazem with digoxin
Number of subjects: 24
Study: 3963154

Group type: EXPERIMENTAL
Intervention: Morphine and glycopyrrolate
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Morphine and scopolamine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Morphine alone
Number of subjects: 30
Study: 31542446

Group type: EXPERIMENTAL
Intervention: Customized Consumer Medication Information (C-CMI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 0
Study: 30241151

Group type: EXPERIMENTAL
Intervention: Patients treated in the United States/Canada (USC)
Number of subjects: 4736

Group type: COMPARATOR
Intervention: Patients treated in Western Europe
Number of subjects: 4736

Group type: COMPARATOR
Intervention: Patients treated in Latin America, Asia/Oceania/Africa, and Eastern Europe
Number of subjects: 4736

Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 4736
Study: 27488457

Group type: EXPERIMENTAL
Intervention: KiVa anti-bullying program
Number of subjects: 2042

Group type: COMPARATOR
Intervention: Control (usual school provision)
Number of subjects: 2042
Study: 25694243

Group type: EXPERIMENTAL
Intervention: low-frequency tRNS (lf-tRNS)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: high-frequency tRNS (hf-tRNS)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: whole frequency spectrum tRNS (wf-tRNS)
Number of subjects: 154
Study: 23948349

Group type: EXPERIMENTAL
Intervention: Dose-dense treatment (carboplatin AUC 6 mg/mL per min on day 1 and paclitaxel 80 mg/m2 on days 1, 8, and 15)
Number of subjects: 637

Group type: COMPARATOR
Intervention: Conventional treatment (carboplatin AUC 6 mg/mL per min and paclitaxel 180 mg/m2 on day 1)
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Dose-dense treatment
Number of subjects: 637

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 637
Study: 20104529

Group type: EXPERIMENTAL
Intervention: Polaprezinc
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (azulene oral rinse)
Number of subjects: 31
Study: 18386641

Group type: EXPERIMENTAL
Intervention: Transcutaneous acupoint electrical stimulation (TAES)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 16807754

Group type: EXPERIMENTAL
Intervention: Dyed test formulation administered intranasally
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Lateral head position during administration
Number of subjects: 10
Study: 14682142

Group type: EXPERIMENTAL
Intervention: Accelerated hyperfractionation (AHF) 1.3 Gy, twice a day, 5 weeks, total 57.2-70 Gy
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Accelerated hyperfractionation (AHF) 1.5 Gy, total 54-63 Gy
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Accelerated hyperfractionation (AHF) 1.7 Gy, total 56.1-57.83 Gy
Number of subjects: 303

Group type: COMPARATOR
Intervention: Standard fractionation (SF), total 58-70 Gy
Number of subjects: 303
Study: 11007216

Group type: EXPERIMENTAL
Intervention: 0.1 N hydrochloric acid perfusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Comparison of acid perfusion to saline perfusion
Number of subjects: 12
Study: 8615463

Group type: EXPERIMENTAL
Intervention: knee-high, foam, single-pulse IPC device
Number of subjects: 26

Group type: COMPARATOR
Intervention: thigh-high, vinyl, sequential-pulse IPC system
Number of subjects: 26
Study: 1535419

Group type: EXPERIMENTAL
Intervention: Aspirin before myocardial infarction
Number of subjects: 2231

Group type: EXPERIMENTAL
Intervention: Aspirin after myocardial infarction
Number of subjects: 2231

Group type: EXPERIMENTAL
Intervention: Calcium antagonists after myocardial infarction
Number of subjects: 2231
Study: 6727354

Group type: EXPERIMENTAL
Intervention: 3H‐labelled oestradiol
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 3H‐labelled oestriol
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 3H‐labelled oestradiol and oestriol
Number of subjects: 3
Study: 30515552

Group type: EXPERIMENTAL
Intervention: Algorithm A
Number of subjects: 45739

Group type: EXPERIMENTAL
Intervention: Algorithm B
Number of subjects: 45739

Group type: EXPERIMENTAL
Intervention: Algorithm C
Number of subjects: 45739
Study: 27684533

Group type: EXPERIMENTAL
Intervention: trastuzumab
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: lapatinib
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: combination of trastuzumab and lapatinib
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: weekly paclitaxel
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: fluorouracil, epirubicin, and cyclophosphamide
Number of subjects: 455
Study: 26293315

Group type: EXPERIMENTAL
Intervention: PTNS (Percutaneous tibial nerve stimulation)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 227